Background: The Kidney Research Scientist Core Education and National Training (KRESCENT) Program was launched in 2005 to enhance kidney research capacity in Canada and foster knowledge translation across the 4 themes of health research.

Objective: To evaluate the impact of KRESCENT on its major objectives and on the careers of trainees after its first 10 years.

Methods: An online survey of trainees (n = 53) who had completed or were enrolled in KRESCENT was conducted in 2015. Information was also obtained from curriculum vitae (CVs). A bibliometric analysis assessed scientific productivity, collaboration, and impact in comparison with unsuccessful applicants to KRESCENT over the same period. The analysis included a comparison of Canadian with international kidney research metrics from 2000 to 2014.

Results: Thirty-nine KRESCENT trainees completed the survey (74%), and 44 trainees (83%) submitted CVs. KRESCENT trainees had a high success rate at obtaining grant funding from the Canadian Institutes of Health Research (CIHR; 79%), and 76% of Post-Doctoral Fellows received academic appointments at the Assistant Professor level within 8 months of completing training. The majority of trainees reported that KRESCENT had contributed significantly to their success in securing CIHR funding (90%), and to the creation of knowledge (93%) and development of new methodologies (50%). Bibliometric analysis revealed a small but steady decline in total international kidney research output from 2000 to 2014, as a percentage of all health research, although overall impact of kidney research in Canada increased from 2000-2005 to 2009-2014 compared with other countries. KRESCENT trainees demonstrated increased productivity, multiauthored papers, impact, and international collaborations after their training, compared with nonfunded applicants.

Conclusions: The KRESCENT Program has fostered kidney research career development and contributed to increased capacity, productivity, and collaboration. To further enhance knowledge creation and translation in kidney research in Canada, programs such as KRESCENT should be sustained via long-term funding partnerships.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317037PMC
http://dx.doi.org/10.1177/2054358117693354DOI Listing

Publication Analysis

Top Keywords

krescent program
12
krescent trainees
12
krescent
11
kidney
8
trainees completed
8
bibliometric analysis
8
productivity collaboration
8
international kidney
8
kidney canada
8
trainees
7

Similar Publications

Background: Patients who experienced acute kidney injury (AKI) may benefit from dedicated care following hospital discharge. Most of these patients will be followed by primary care providers. There is a lack of data on current practices and comfort for these care providers when offering post-AKI care.

View Article and Find Full Text PDF
Article Synopsis
  • * The study included 60 adult patients starting hemodialysis in Alberta, Canada, examining the effects of sex assigned at birth and gender identity on changes in physical and mental health quality of life over three months.
  • * Results showed that women on conventional hemodialysis experienced improved physical health, while those on incremental hemodialysis noted better mental health; no changes were seen in male participants regardless of the type of hemodialysis.
View Article and Find Full Text PDF

Purpose Of Review: Chronic kidney disease (CKD)-associated pruritus is a common, persistent, and distressing itch experienced by patients across the CKD spectrum. Although the disorder is associated with adverse outcomes and poor health-related quality of life, it remains underdiagnosed and undertreated. The purpose of this narrative review is to offer health care providers guidance on how to effectively identify, assess, and treat patients with CKD-associated pruritus, with the goal of reducing symptom burden and improving patient-important outcomes, such as quality of life (QoL).

View Article and Find Full Text PDF

Predicting Outcomes in Nephrology: Lots of Tools, Limited Uptake: How Do We Move Forward?

J Am Soc Nephrol

March 2024

Medicine, Division of Nephrology, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada.

View Article and Find Full Text PDF

Background: There is a lack of randomized controlled trial data regarding differences in immunogenicity of varying coronavirus disease 2019 (COVID-19) mRNA vaccine regimens in CKD populations.

Methods: We conducted a randomized controlled trial at three kidney centers in Toronto, Ontario, Canada, evaluating the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response after third dose vaccination. Participants ( n =273) with CKD not on dialysis or receiving dialysis were randomized 1:1 to third dose 30- µ g BNT162b2 (Pfizer-BioNTech) or 100- µ g mRNA-1273 (Moderna).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!